Moderna seeks COVID-19 vaccine authorization for teens


Moderna is seeking FDA authorization for use of its COVID-19 vaccine among people ages 12 to 17. The vaccine by Pfizer and German partner BioNTech has already been authorized for that age range, and more than 7 million Americans in that group have received at least one dose.

Full story:

AIChE SmartBrief

Chemical engineering news

Designed specifically for chemical engineers, AIChE SmartBrief is a FREE weekly e-mail newsletter. It helps chemical engineers stay informed on the business and technology developments affecting our profession.